Skip to main content
Log in

Behçet’s disease: An update

  • Original Articles
  • Published:
Comprehensive Therapy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Feigenbaum A. Description of Behçet’s disease in the Hippocratic third book of endemic diseases.Br J Ophthalmol. 1956;40:355–357.

    Article  PubMed  CAS  Google Scholar 

  2. Behçet H. Ueber rezivierende aphthose durch ein virus verursachte geschwuere am mund, am auge und an den genitalien.Dermatol Wochenschr. 1937;105:1152–1157.

    Google Scholar 

  3. Bang D, Lee E-S, Lee S.Reference Index Related to Behçet’s Disease. 2nd ed. Seoul, Korea: Yonsei University College of Medicine; 1958.

    Google Scholar 

  4. Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behçet disease (Behçet syndrome).Semin Arthritis Rheum. 1979;8:223–260.

    Article  PubMed  CAS  Google Scholar 

  5. Davatchi F, Shahram F, Akbarian K Gharibdoost F, Nadji A, Chams C, et al. Behçet’s disease: analysis of 3443 cases.J Rheumatol. 1997;1:2–5.

    Google Scholar 

  6. Chapoutot-Remadi M. Major trade routes and the ‘silk road.’ In: Hamza M, ed.Proceedings of the 7th International Conference on Behçet’s Disease, 1996. 1997:22–27.

  7. Ehrlich GE. Periodic and intermittent rheumatic syndromes. In: Hollander JL, McCarty D, eds.Arthritis. 9th ed. Philadelphia, Pa: Lea & Febiger; 1979.

    Google Scholar 

  8. Ehrlich GE. Behçet’s disease: now you see it, now you don’t.Compr Ther. 1992;18(9):25–7.

    PubMed  CAS  Google Scholar 

  9. APLAR Subcommittee for Behçet’s Disease. APLAR evaluation of Behçet’s disease diagnostic criteria.J Rheumatol. 1998;1:237–240.

    Google Scholar 

  10. International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease.Lancet. 1990;335:1078–1080.

    Google Scholar 

  11. Kaklamani V, Vaiopoulos G, Kaklamanis PG. Behçet’s disease.Semin Arthritis Rheum. 1998;27:197–217.

    Article  PubMed  CAS  Google Scholar 

  12. Sakane T. New perspective on Behçet’s disease.Int Rev Immunol. 1997;14:87–96.

    Google Scholar 

  13. Mizushima Y. Recent research into Behçet’s disease in Japan.Int J Tissue React. 1988;10:59–65.

    PubMed  CAS  Google Scholar 

  14. Ohno S, Goto K. HLA association in Behçet’s disease.8th International Congress on Behçet’s Disease: Program and Abstracts. 1998:44.

  15. Mizuki N. Pathogenic gene responsible for the predisposition to Behçet’s disease.Int Rev Immunol. 1997;14:33–48.

    PubMed  CAS  Google Scholar 

  16. Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet’s disease.Int Rev Immunol. 1997;14:21–32.

    PubMed  CAS  Google Scholar 

  17. Gul A, Esin S, Dilsen N, Konice NT, Wigzell K, Biberfeld B. Immunohistology of skin pathergy reaction in Behçet’s disease.Br J Dermatol. 1995;132:901–907.

    PubMed  CAS  Google Scholar 

  18. Yazici H. The place of Behçet’s syndrome among the autoimmune diseases.Int Rev Immunol. 1997;1:1–10.

    Google Scholar 

  19. Marsal S, Falga C, Simeon CP, Vilardell NL, Bosch JA. Behçet’s disease and pregnancy relationship study.Br J Rheumatol. 1997;36:234–238.

    Article  PubMed  CAS  Google Scholar 

  20. Alekberova C, Nassonov E, Reshetnjak T, Prokaeva T. Antiphospholipid antibodies in Behçet’s disease.8th International Congress on Behçet’s Disease: Program and Abstracts. 1998:156.

  21. Cipriani MD, Ossandon A, Priori R, Alessandri C, Caferro K, La Magrini A, et al. Anti-calpastatin antibodies and thrombosis in Behçet’s disease.8th International Congress on Behçet’s Disease: Program and Abstracts. 1998:161.

  22. Ehrlich GE, Kajani NL, Schwartz K, McAlack RF. Further studies of platelet rosettes around granulocytes in Behçet’s syndrome.Inflammation. 1975–76;1:223–229.

    Article  Google Scholar 

  23. Mehmet S, Kahraman T, Rikkat K, Suleyman O, Eren E. Factor V Leiden mutation in Behçet’s disease.8th International Congress on Behçet’s Disease: Program and Abstracts. 1998:170.

  24. Yazici H. A critical appraisal of therapy of Behçet’s syndrome (BS).8th International Congress on Behçet’s Disease: Program and Abstracts. 1998:90.

  25. Hamuryudan V. Drug treatment.8th International Congress on Behçet’s Disease: Program and Abstracts. 1998:88.

  26. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome: a randomized, double-blind, placebo-controlled trial.Ann Intern Med. 1998;128:443–450.

    PubMed  CAS  Google Scholar 

  27. Hamza MH. Treatment of Behçet’s disease with thalidomide.Clin Rheumatol (Belg). 1986;5:365–371.

    Article  CAS  Google Scholar 

  28. Jorizzo JL, Schmalstieg FC, Solomon AR, Cavallo T, Taylor RS, Rudloff HB, et al. Thalidomide effects in Behçet’s syndrome and pustular vasculitis.Arch Intern Med. 1986;146:878–881.

    Article  PubMed  CAS  Google Scholar 

  29. Ehrlich GE. Behçet’s disease and the emergence of thalidomide.Ann Intern Med. 1998;128:484–485.

    Google Scholar 

  30. Demiroglu K, Yalcin S, Buyukasik Y. Mucocutaneous lesions in the Behçet syndrome.Ann Intern Med. 1998;129:836.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Ehrlich, G.E. Behçet’s disease: An update. Compr Ther 25, 216–220 (1999). https://doi.org/10.1007/BF02889622

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02889622

Keywords

Navigation